Embecta Corp., (EMBC): Price and Financial Metrics
EMBC Price/Volume Stats
| Current price | $27.34 | 52-week high | $36.64 |
| Prev. close | $26.88 | 52-week low | $22.30 |
| Day low | $26.37 | Volume | 297,000 |
| Day high | $27.56 | Avg. volume | 629,922 |
| 50-day MA | $28.43 | Dividend yield | 2.23% |
| 200-day MA | $29.54 | Market Cap | 1.57B |
EMBC Stock Price Chart Interactive Chart >
EMBC POWR Grades
- Value is the dimension where EMBC ranks best; there it ranks ahead of 98.01% of US stocks.
- EMBC's strongest trending metric is Growth; it's been moving down over the last 127 days.
- EMBC's current lowest rank is in the Momentum metric (where it is better than 6.83% of US stocks).
EMBC Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for EMBC is -1.36 -- better than just 5.07% of US stocks.
- EMBECTA CORP's stock had its IPO on April 1, 2022, making it an older stock than merely 0.5% of US equities in our set.
- EMBC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 5.42% of US stocks.
- If you're looking for stocks that are quantitatively similar to EMBECTA CORP, a group of peers worth examining would be SANW, MTRN, AIN, DBD, and NLS.
- To check out EMBECTA CORP's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001872789.
EMBC Valuation Summary
- EMBC's price/sales ratio is 1.5; this is 31.82% lower than that of the median Healthcare stock.
- Over the past 14 months, EMBC's price/sales ratio has gone down 0.
Below are key valuation metrics over time for EMBC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| EMBC | 2023-05-23 | 1.5 | -2.0 | 17.4 | 13.3 |
| EMBC | 2023-05-22 | 1.4 | -1.9 | 16.3 | 12.9 |
| EMBC | 2023-05-19 | 1.4 | -1.9 | 16.4 | 12.9 |
| EMBC | 2023-05-18 | 1.5 | -2.0 | 17.3 | 13.3 |
| EMBC | 2023-05-17 | 1.4 | -1.9 | 17.0 | 13.1 |
| EMBC | 2023-05-16 | 1.5 | -2.0 | 17.5 | 13.4 |
Embecta Corp., (EMBC) Company Bio
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Latest EMBC News From Around the Web
Below are the latest news stories about EMBECTA CORP that investors may wish to consider to help them evaluate EMBC as an investment opportunity.
Just Four Days Till Embecta Corp. (NASDAQ:EMBC) Will Be Trading Ex-DividendEmbecta Corp. ( NASDAQ:EMBC ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set to... |
UPDATE -- embecta to Participate in Investor ConferencesPARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences: 2023 RBC Capital Markets Global Healthcare Conference Management will host a fireside session on Tuesday, May 16, 2023, at 3:05 p.m. Eastern Time (ET) at the InterContinental Barclay, New York. Audio webcasts of the presentations will be accessible und |
embecta to Participate in Investor ConferencesPARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences: 2023 RBC Capital Markets Global Healthcare Conference Management will host a fireside session on Tuesday, May 16, 2023, at 3:05 p.m. Eastern Time (ET) at the InterContinental Barclay, New York. Audio webcasts of the presentations will be accessible und |
Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for InvestorsGood things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react? |
Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving AverageGood things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react? |
EMBC Price Returns
| 1-mo | -5.74% |
| 3-mo | -9.82% |
| 6-mo | -13.76% |
| 1-year | 1.44% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 9.20% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
EMBC Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...